Optimi Health is trading 5.66% up now at $4.67, with no clear company-specific catalyst identified for September 14, 2026.
- Latest coverage discusses the H.C. Wainwright conference and planned FDA psychedelic hearings.
- Neither event is explicitly connected to the stock’s intraday move.
- The recent Phase 2 depression-trial announcement is prior context, not a confirmed explanation for today’s increase.